Ad is loading...
JHUJX
Price
$29.45
Change
-$0.23 (-0.77%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

JHUJX vs RNWFX

Header iconJHUJX vs RNWFX Comparison
Open Charts JHUJX vs RNWFXBanner chart's image
JPMorgan Emerging Markets Equity R2
Price$29.45
Change-$0.23 (-0.77%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
JHUJX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JHUJX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHUJX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. JHUJX (6.96B). RNWFX pays higher dividends than JHUJX: RNWFX (1.51) vs JHUJX (1.01). JHUJX was incepted earlier than RNWFX: JHUJX (7 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. JHUJX (29.00). JHUJX has a lower initial minimum investment than RNWFX: JHUJX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. JHUJX (8.33). RNWFX return over 5 years is better than : 17.17 vs. JHUJX (-0.59).
JHUJXRNWFXJHUJX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD3.8077.09954%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.96B60.9B11%
Annual Yield % from dividends1.011.5167%
Returns for 1 year8.3311.5472%
Returns for 3 years-27.15-14.55187%
Returns for 5 years-0.5917.17-3%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics